The global economic downturn has upended growth plans of virtually all companies in the healthcare sector. Credit has tightened, healthcare providers are under financial stress, device and diagnostic manufacturers are seeking to reduce production costs and more efficiently innovate, and pharmaceutical companies are shoring up product portfolios as
patents expire. On top of this upheaval, the Obama Administration is preparing to create new regimes in healthcare delivery, expenditures and reimbursements, with results that are difficult to predict.

This Insight conference, bringing together major leaders in a wide range of healthcare, M&A, and business development disciplines, will analyze these complicated issues and provide insights into how best to navigate them to reach successful business results. Real world challenges and real world solutions will be articulated. Major trends affecting
Healthcare M&A and Business Development will be examined.

The business of healthcare is at an historical turning point. This conference will provide the tools and perspective necessary to excel in this new environment.